CBUS - Cibus, Inc. Stock Analysis

Stock Taper

OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

CBUS

CIBUS, INC.

NASDAQ

$1.61

▼ DOWN 1.23% (-0.02)

KEY STATISTICS

Market Cap$122.89 M

52w High$4.19

52w Low$1.09

Dividend Yield—

Frequency—

P/E-0.89

Volume139.15K

Shares Out.76.33M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Craig Wichner

COMPENSATION 2026

Salary$630,579

Stock Awards$276,100

Incentive Plan Pay$0

All Other Comp.$0

Total$1,364,345

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 20, 2017

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

118

PRICE TARGET

Target High$12.50

Target Low$10.50

Target Median$11.50

Target Consensus$11.50

UPCOMING EARNINGS

DateNov 12, 2026

DayThursday

Rev. Est.$1.30M

NOV

THU

SPLIT RECORD

DATE	TYPE	RATIO
2023-06-01	Reverse	1:5
2023-04-25	Reverse	1:10

PRICE

$1.61 ▼ DOWN 1.23% (−$0.02)

OVERLAYS

About Cibus, Inc.

https://www.cibus.com ↗

Cibus, Inc. is an agricultural tech company in San Diego that develops and licenses plant traits to boost yields, reduce chemical use, and enable sustainable ingredient replacements for seed companies.

INDUSTRY

Biotechnology

A PRODUCT CIBUS, INC. IS KNOWN FOR

Second-Generation Herbicide Tolerance (HT2) Trait in Canola

Cibus's gene-edited canola trait offers herbicide tolerance for improved weed management, with successful 2025 field trials and a "not regulated" USDA status paving the way for commercial launch.